Published in J Biol Chem on June 02, 1995
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol (2007) 3.04
The role of ABCE1 in eukaryotic posttermination ribosomal recycling. Mol Cell (2010) 2.14
Biogenesis of cytosolic ribosomes requires the essential iron-sulphur protein Rli1p and mitochondria. EMBO J (2005) 1.87
Kinetic analysis reveals the ordered coupling of translation termination and ribosome recycling in yeast. Proc Natl Acad Sci U S A (2011) 1.78
New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res (2010) 1.73
Functional link between ribosome formation and biogenesis of iron-sulfur proteins. EMBO J (2005) 1.67
RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. J Virol (1998) 1.44
A scientific journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev (2007) 1.42
The iron-sulphur protein RNase L inhibitor functions in translation termination. EMBO Rep (2010) 1.40
Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol (2010) 1.31
Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1. Proc Natl Acad Sci U S A (2011) 1.26
Evolutionary analyses of ABC transporters of Dictyostelium discoideum. Eukaryot Cell (2002) 1.23
Diverse functions of RNase L and implications in pathology. Biochimie (2007) 1.21
The ABC transporter gene family of Daphnia pulex. BMC Genomics (2009) 1.20
The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol (2000) 1.14
Functional analysis of the ATP-binding cassette (ABC) transporter gene family of Tribolium castaneum. BMC Genomics (2013) 1.11
RNase L mediated protection from virus induced demyelination. PLoS Pathog (2009) 1.10
Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells. J Virol (2004) 1.08
A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L. RNA (2008) 1.06
RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol (1999) 1.01
ABC50 promotes translation initiation in mammalian cells. J Biol Chem (2009) 0.99
MicroRNA analysis of microdissected normal squamous esophageal epithelium and tumor cells. Am J Cancer Res (2011) 0.97
RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation. Cell Death Differ (2012) 0.95
A plant orthologue of RNase L inhibitor (RLI) is induced in plants showing RNA interference. J Mol Evol (2004) 0.94
Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence. RNA Biol (2009) 0.92
How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle. Virus Res (2014) 0.88
Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cells. PLoS One (2009) 0.88
RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. J Interferon Cytokine Res (2014) 0.88
Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia. J Interferon Cytokine Res (2012) 0.87
Transcriptome-based identification of ABC transporters in the western tarnished plant bug Lygus hesperus. PLoS One (2014) 0.87
Host-rabies virus protein-protein interactions as druggable antiviral targets. Proc Natl Acad Sci U S A (2013) 0.86
Role of ribonuclease L in viral pathogen-associated molecular pattern/influenza virus and cigarette smoke-induced inflammation and remodeling. J Immunol (2013) 0.86
Whole-genome survey of the putative ATP-binding cassette transporter family genes in Vitis vinifera. PLoS One (2013) 0.85
Pathologic effects of RNase-L dysregulation in immunity and proliferative control. Front Biosci (Schol Ed) (2012) 0.83
Can't RIDD off viruses. Front Microbiol (2014) 0.83
Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people. Cell Death Dis (2014) 0.82
Inventory and comparative evolution of the ABC superfamily in the genomes of Phytophthora ramorum and Phytophthora sojae. J Mol Evol (2009) 0.81
Analysis of two domains with novel RNA-processing activities throws light on the complex evolution of ribosomal RNA biogenesis. Front Genet (2014) 0.81
Depleting ABCE1 expression induces apoptosis and inhibits the ability of proliferation and migration of human esophageal carcinoma cells. Int J Clin Exp Pathol (2014) 0.81
Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells. Int J Clin Exp Pathol (2014) 0.80
Deciphering structure and topology of conserved COG2042 orphan proteins. BMC Struct Biol (2005) 0.79
Varicella-zoster virus does not significantly induce cell defence mechanism mediated by the 2-5A/RNase L pathway during its replication cycle. Med Microbiol Immunol (2005) 0.79
Genome-wide identification and evolution of ATP-binding cassette transporters in the ciliate Tetrahymena thermophila: A case of functional divergence in a multigene family. BMC Evol Biol (2010) 0.79
Marine medaka ATP-binding cassette (ABC) superfamily and new insight into teleost Abch nomenclature. Sci Rep (2015) 0.78
Oligosyndactylism mice have an inversion of chromosome 8. Genetics (2004) 0.78
ABCE1 is a highly conserved RNA silencing suppressor. PLoS One (2015) 0.77
Probabilistic orthology analysis of the ATP-binding cassette transporters: implications for the development of multiple drug resistance phenotype. Drug Metab Dispos (2012) 0.77
The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response. Int J Mol Sci (2016) 0.76
Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides. BMC Biochem (2015) 0.75
An excess of rare genetic variation in ABCE1 among Yorubans and African-American individuals with HIV-1. Genes Immun (2009) 0.75
Structure of the ribosome post-recycling complex probed by chemical cross-linking and mass spectrometry. Nat Commun (2016) 0.75
ABCE1 is essential for S phase progression in human cells. Cell Cycle (2016) 0.75
A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem (1997) 6.52
A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med (2000) 3.54
Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A (1976) 3.24
Specific antiviral activity of a poly(L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci U S A (1987) 3.00
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Intracellular distribution of microinjected antisense oligonucleotides. Proc Natl Acad Sci U S A (1991) 2.22
Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. Proc Natl Acad Sci U S A (1974) 2.05
Correlation between the antiviral effect of interferon treatment and the inhibition of in vitro mRNA translation in noninfected L cells. J Virol (1973) 2.00
Interferon, double-stranded RNA and mRNA degradation. Nature (1976) 1.70
TAT peptide internalization: seeking the mechanism of entry. Curr Protein Pept Sci (2003) 1.66
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res (1986) 1.62
Delivery of antisense oligonucleotides by poly(L-lysine) conjugation and liposome encapsulation. Anticancer Drug Des (1993) 1.61
Discrimination between messenger ribonucleic acids by a mammalian translation initiation factor. Proc Natl Acad Sci U S A (1973) 1.57
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
alpha-DNA. VI: Comparative study of alpha- and beta-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition. Nucleic Acids Res (1987) 1.53
Cell-penetrating-peptide-based delivery of oligonucleotides: an overview. Biochem Soc Trans (2007) 1.49
Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol Dis (2008) 1.39
Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun (1976) 1.37
Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol Cell Biol (1991) 1.36
Release of messenger RNA from rabbit reticulocyte polyribosomes at low concentration of divalent cations. Biochim Biophys Acta (1967) 1.35
Comparative evaluation of seven oligonucleotide analogues as potential antisense agents. J Med Chem (1993) 1.27
Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconjug Chem (1991) 1.22
Mechanisms of interferon action: biochemical and genetic approaches. Interferon (1982) 1.22
Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo. Biochem Soc Trans (2007) 1.17
Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem (1977) 1.14
The 2'-5' oligoadenylate/RNase L/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol (2000) 1.14
Antiviral activity of conjugates between poly(L-lysine) and synthetic oligodeoxyribonucleotides. Gene (1988) 1.14
Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells. Eur J Biochem (1975) 1.13
Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol (1975) 1.11
Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucleic Acids Res (1994) 1.10
The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells. J Biol Chem (2001) 1.10
Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem Soc Trans (2007) 1.09
Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication. Proc Natl Acad Sci U S A (1990) 1.09
Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol (1977) 1.08
Effect of aurintricarboxylic acid and of NaF on the binding of globin messenger RNA to reticulocyte 40S ribosomal subunits. Biochem Biophys Res Commun (1970) 1.07
Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells. Biochem Biophys Res Commun (1975) 1.06
Reversible inhibition of gene expression by a psoralen functionalized triple helix forming oligonucleotide in intact cells. J Biol Chem (1994) 1.04
Mechanism of the interferon-induced block of mRNA translation in mouse L cells: reversal of the block by transfer RNA. FEBS Lett (1974) 1.03
RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol (1999) 1.01
Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells. Biochemistry (1986) 1.00
Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci (2008) 1.00
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res (1999) 0.98
Interferon treatment inhibits Mengo RNA and haemoglobin mRNA translation in cell-free extracts of L cells. Nat New Biol (1972) 0.97
Antibody targeted liposomes containing poly(rI).poly(rC) exert a specific antiviral and toxic effect on cells primed with interferons alpha/beta or gamma. Biochim Biophys Acta (1989) 0.96
RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation. Cell Death Differ (2012) 0.95
Antiviral activity and possible mechanisms of action of oligonucleotides-poly(L-lysine) conjugates targeted to vesicular stomatitis virus mRNA and genomic RNA. Nucleic Acids Res (1989) 0.95
Cell delivery and mechanisms of action of antisense oligonucleotides. Prog Nucleic Acid Res Mol Biol (1993) 0.95
Characterization of the nuclear binding sites of oligodeoxyribonucleotides and their analogs. J Biol Chem (1993) 0.94
Translation of mouse interferon mRNA in Xenopus laevis oocytes and in rabbit reticulocyte lysates. Biochem Biophys Res Commun (1978) 0.93
Isolation of rabbit reticulocyte 9 S mRNA. Methods Enzymol (1974) 0.93
Evidence for a naF-resistant association between mRNA and ribosomes in rabbit reticulocytes. Biochim Biophys Acta (1967) 0.93
Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNalpha-induced apoptosis. Cell Death Differ (2007) 0.91
RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur J Biochem (1998) 0.91
Isolation of Daudi cells with reduced sensitivity to interferon. II. On the mechanisms of resistance. J Gen Virol (1983) 0.90
Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. Nucleic Acids Res (1991) 0.89
Alpha-DNA.IX: Parallel annealing of alpha-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription. Nucleic Acids Res (1989) 0.89
Sequence-specific inhibition of human immunodeficiency virus (HIV) reverse transcription by antisense oligonucleotides: comparative study in cell-free assays and in HIV-infected cells. Proc Natl Acad Sci U S A (1995) 0.89
Structure of globin mRNA and mRNA-protein particles. Use of dark-field electron microscopy. Eur J Biochem (1973) 0.89
Differential effects of various double-stranded RNAs on protein synthesis in rabbit reticulocyte lysates. Biochemistry (1978) 0.89
Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides. Antisense Nucleic Acid Drug Dev (1998) 0.89
Microinjected interferon does not promote an antiviral response in Hela cells. Biochem Biophys Res Commun (1983) 0.88
Mesenger ribonucleoprotein and initiation factors in rabbit-reticulocyte polyribosomes. Eur J Biochem (1973) 0.87
Antisense inhibitors of HIV: problems and perspectives. Antiviral Res (1992) 0.86
Placental BDNF/TrkB signaling system is modulated by fetal growth disturbances in rat and human. Placenta (2010) 0.86
Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res Dev (1992) 0.85
Characterization of two murine (2'-5')(A)n-dependent endonucleases of different molecular mass. Eur J Biochem (1989) 0.85
Messenger RNA methylation, translation and degradation in extracts of interferon-treated cells. Tex Rep Biol Med (1977) 0.85
Perinatal undernutrition modifies cell proliferation and brain-derived neurotrophic factor levels during critical time-windows for hypothalamic and hippocampal development in the male rat. J Neuroendocrinol (2009) 0.84
Comparison of interferon action in interferon resistant and sensitive L1210 cells. J Gen Virol (1978) 0.84
cDNA cloning and expression analysis of the murine ribonuclease L inhibitor. Gene (1998) 0.83
Oligonucleotide-poly(L-lysine)-heparin complexes: potent sequence-specific inhibitors of HIV-1 infection. Bioconjug Chem (1994) 0.83
Characterization of RNABP, an RNA binding protein that associates with RNase L. J Interferon Cytokine Res (2000) 0.83
Antiviral activity in L1210 cells of liposome-encapsulated (2'-5')oligo(adenylate) analogues. Eur J Biochem (1985) 0.83
Inhibition of a DNA-helicase by peptide nucleic acids. Nucleic Acids Res (1999) 0.83
The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms. Biochimie (1988) 0.83
The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI). Methods Mol Biol (2001) 0.82
Dual response of BDNF to sublethal concentrations of beta-amyloid peptides in cultured cortical neurons. Neurobiol Dis (2009) 0.81
In vivo brain-derived neurotrophic factor release and tyrosine kinase B receptor expression in the supraoptic nucleus after osmotic stress stimulus in rats. Neuroscience (2007) 0.81
2',5'-Oligoadenylate-dependent RNase L is a dimer of regulatory and catalytic subunits. J Biol Chem (1993) 0.81
Polyclonal antibodies against RNase L. Subcellular localization of this enzyme in mouse cells. J Biol Chem (1991) 0.81
Localization of the ribonuclease L inhibitor gene (RNS4I), a new member of the interferon-regulated 2-5A pathway, to 4q31 by fluorescence in situ hybridization. Genomics (1996) 0.81